Related Experiment Video
Updated: Mar 8, 2026

13:51
Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
Published on: November 11, 2018
10.4K
A fully automated procedure for the parallel, multidimensional purification and nucleotide loading of the human
Christopher H Gray1, Jennifer Konczal1, Mokdad Mezna1
1Drug Discovery Program, CRUK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK.
Protein Expression and Purification
|February 1, 2017
Summary
Automated protein purification enables efficient production of active small GTPases, crucial for drug discovery. This method streamlines the preparation of KRas, Rac1, and RalB for therapeutic target validation and structural studies.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Discovery
Background:
- Small GTPases are vital regulators of cellular processes and implicated in human diseases.
- Active, GTP-bound forms of GTPases are essential for drug discovery efforts.
- Conventional methods for producing active GTPases are complex and limit supply.
Purpose of the Study:
- To establish a fully automated, multidimensional protein purification strategy for parallel production of active GTPase G-domains.
- To enable efficient loading of GTPases with nucleotide analogues for drug discovery assays.
Main Methods:
- Four-step chromatography purification with TEV protease cleavage.
- Automated conditioning step for GDP to GMPPnP exchange (GTPase activation).
- Automated loading of KRas with mantGDP for fluorescent nucleotide exchange assays.
Main Results:
- Successful parallel production of active KRas, Rac1, and RalB catalytic G-domains.
- Demonstrated efficiency of automated KRas loading with mantGDP for functional assays.
- Significant reduction in method run time and operator workload compared to manual methods.
Conclusions:
- The automated method provides a streamlined and efficient approach for producing highly purified, active GTPases.
- This strategy overcomes bottlenecks in protein production for structure-based drug discovery.
- The method supports the development of novel therapeutics targeting small GTPases.

